Back
CapitaLand Investment Ltd. Vs. Bright Minds Biosciences, Inc. Industry Stock Comparison
Buy
60
CLILF
CapitaLand Investment Ltd.
Last Price:
$2.19
Seasonality Move:
0.19%
Sell
45
DRUG
Bright Minds Biosciences, Inc.
Last Price:
$81.75
Seasonality Move:
-32.16%
Buy
60
CapitaLand Investment Ltd. (CLILF)
is a Buy
Is CapitaLand Investment Ltd. a Buy, Sell or Hold?
-
The current CapitaLand Investment Ltd. [CLILF] share price is $2.19. The Score for CLILF is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
-
CLILF is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
45
Bright Minds Biosciences, Inc. (DRUG)
is a Sell
Is Bright Minds Biosciences, Inc. a Buy, Sell or Hold?
-
The current Bright Minds Biosciences, Inc. [DRUG] share price is $78.88. The Score for DRUG is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
-
DRUG is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CLILF Stock Price Chart
What is CapitaLand Investment Ltd.'s stock price today?
-
The CapitaLand Investment Ltd. share price today is $2.19Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CLILF is experiencing slight buying pressure.
DRUG Stock Price Chart
What is Bright Minds Biosciences, Inc.'s stock price today?
-
The Bright Minds Biosciences, Inc. share price today is $78.88The current trend is moderately bullish and DRUG is experiencing selling pressure, which indicates risk of future bearish movement.
CLILF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.11 | Buy |
| Relative Strength Index (14 RSI): | 94.06 | Buy |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.42 - 1.84) | Buy |
| Bollinger Bands (100): | (1.63 - 2.11) | Buy |
DRUG Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 6.94 | Buy |
| Relative Strength Index (14 RSI): | 54.75 | Buy |
| Chaikin Money Flow: | -145421 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (60.39 - 83.51) | Buy |
| Bollinger Bands (100): | (41.65 - 69.37) | Buy |
CLILF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.83 | Buy |
| 20-day SMA: | 1.66 | Buy |
| 50-day SMA: | 1.69 | Buy |
| 200-day SMA: | 1.86 | Buy |
| 8-day EMA: | 1.92 | Buy |
| 20-day EMA: | 1.74 | Buy |
| 50-day EMA: | 1.73 | Buy |
| 200-day EMA: | 1.85 | Buy |
DRUG Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 85.2 | Sell |
| 20-day SMA: | 75.43 | Buy |
| 50-day SMA: | 66.05 | Buy |
| 200-day SMA: | 43.03 | Buy |
| 8-day EMA: | 83.79 | Sell |
| 20-day EMA: | 77.26 | Buy |
| 50-day EMA: | 67.4 | Buy |
| 200-day EMA: | 47.62 | Buy |
CapitaLand Investment Ltd. Earnings Growth & CLILF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Bright Minds Biosciences, Inc. Earnings Growth & DRUG Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.44 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.89 per share, and a decrease next year of $3.34 per share.
CapitaLand Investment Ltd. Technical Analysis
| Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Bright Minds Biosciences, Inc. Technical Analysis
| Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||